•
Sep 30, 2023
Johnson & Johnson Q3 2023 Earnings Report
Johnson & Johnson reported strong results driven by innovative medicine and medtech solutions.
Key Takeaways
Johnson & Johnson's Q3 2023 results showed a sales growth of 6.8% reaching $21.4 billion and an EPS of $1.69, which increased by 4.3%. The adjusted EPS was $2.66, reflecting a 19.3% increase. The company is increasing its 2023 full-year guidance midpoints for sales and adjusted EPS.
Reported sales growth of 6.8% to $21.4 Billion with operational growth of 6.4%.
Earnings per share (EPS) of $1.69 increasing 4.3%.
Adjusted EPS of $2.66 increasing by 19.3%.
Company is increasing 2023 full-year guidance midpoints for sales and adjusted EPS.
Johnson & Johnson
Johnson & Johnson
Forward Guidance
Johnson & Johnson is increasing 2023 full-year guidance midpoints for sales and adjusted EPS.